Eam Investors, LLC Olema Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$10.53 - $17.14 $159,540 - $259,688	-15,151 Reduced 6.23%	228,139 $3.2 Million
Q3 2023 Nov 13, 2023	BUY	$8.19 - $12.98 $602,456 - $954,808	73,560 Added 43.34%	243,290 $3 Million
Q2 2023 Aug 11, 2023	BUY	$3.22 - $9.65 $546,530 - $1.64 Million	169,730 New	169,730 $1.53 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $247M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.